Skip to content

Shanghai Epidemiology Study for Adolescents and Children with Cancer

Shanghai Epidemiology Study for Adolescents and Children with Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02959086
Enrollment
2000
Registered
2016-11-08
Start date
2002-01-31
Completion date
2030-01-31
Last updated
2025-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Cancer

Keywords

Epidemiology, Shanghai, Cancer, Adolescents, Children

Brief summary

The purpose of this study is to describe the morbidity, mortality, disability and survival rate in Shanghai adolescents and children with cancer diagnosed since January 2002.

Detailed description

The investigators collected information of all the adolescents and children diagnosed cancer in Shanghai since January 2002, including their name, gender, the date of birth, the diagnosis date, disease diagnosis, residence address and the last follow-up time status (survival/death). The type of cancer included all malignant tumors such as Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, central nervous system tumors, Neuroblastoma, Wilms tumor and so on. Then the investigators would analyze the morbidity, mortality, disability and survival rate.

Interventions

None listed

Sponsors

Shanghai Children's Medical Center
CollaboratorOTHER
Shanghai Municipal Center for Disease Prevention & Control
CollaboratorUNKNOWN
Children's Cancer Group, China
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* 0-19 year-old children and adolescents. * Diagnosed cancer in Shanghai since January 2002.

Exclusion criteria

* Patients who were lost of follow-up. * Patient's death wasn't caused by cancer or complications but by other accidents such as car accident, fell from a great height and so on.

Design outcomes

Primary

MeasureTime frame
Overall survival for the whole cohort5 years

Secondary

MeasureTime frame
Mortality for the whole cohort5 years

Other

MeasureTime frame
Disability rate for the whole cohort5 years

Countries

China

Contacts

Primary ContactYi-Jin Gao, MD
gaoyijin@scmc.com.cn0086-21-38626161
Backup ContactXing-Wei Wang, MD
wangxingwei@scmc.com.cn0086-21-38626161

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026